1.	Anti-Retrovirals for Kaposi's Sarcoma Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NIH/NCI Grant #: R01 CA119903, NCT00444379
2.	Phase I/II Study of Anti-VEGF Small Molecule PTC299 in Patients With HIV-Related Kaposi Sarcoma Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: AMC-059, AMC-059, PTC299-ONC-005-KS, NCT00686842
3.	Phase II Pilot Study of Sunitinib Malate in HIV-Seropositive or -Seronegative Patients With Kaposi Sarcoma in East Africa Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: CASE-1706, AMC-049, 7831, CASE 1706, NCT00521092
4.	Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi's Sarcoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 090130, 09-C-0130, NCT00923936
5.	Phase I Study of Interleukin-12 and Interleukin-2 in Patients With Refractory or Advanced Solid Tumors Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-00-C-0121, NCI-41, 41, NCT00020163
6.	Phase I Study of Sorafenib in Patients With Kaposi's Sarcoma Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-06-C-0083, 7048, NCI-7048, NCI-P6700, NCT00304122
7.	Phase I Study of Sunitinib Malate and Hydroxychloroquine in Patients With Advanced Solid Tumors Refractory to Standard Chemotherapy Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: CINJ-050801, 050801, 0220080281, NCT00813423
8.	Pilot Study of High-Dose Zidovudine and Valganciclovir, With or Without Bortezomib or R-EPOCH-R (Comprising Etoposide, Doxorubicin, Vincristine, Prednisone, Cyclophosphamide, and Rituximab) or Sirolimus Only or Observation or HAART Only in Patients With Multicentric Castleman's Disease Associated With Kaposi's Sarcoma-Associated Herpesvirus Phase: No phase specified Type: Treatment Status: Active Age: 12 and over Sponsor: NCI Protocol IDs: NCI-04-C-0275, NCT00099073
9.	Pilot Study of Liposomal Daunorubicin Citrate in Patients With HIV-Related Kaposi's Sarcoma Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: AMC-050, NCT00427414
10.	Pilot Study of Cyclophosphamide and Cryoablation in Patients With Advanced or Metastatic Epithelial Solid Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: JHOC-J0685, NA_00003073, J0685, NCT00499733
11.	Pilot Study of Bortezomib in Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: AMC-063, AMC-063, NCT01016730